Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies

Pulmonary adenocarcinoma patients harboring EGFR mutations can benefit from tyrosine kinase inhibitor therapy. Reliable molecular analyses and precise pathological reporting of the EGFR mutational status are factors essential for patient treatment and outcome. More than 70 % of all EGFR mutation ana...

Full description

Bibliographic Details
Published in:Virchows Archiv, 460(2012), 4, Seite 407-414
Main Author: Warth, Arne (Author)
Other Involved Persons: Penzel, Roland ; Brandt, Regine ; Thomas, Michael ; Herth, Felix ; Schirmacher, Peter ; Bläker, Hendrik
Format: Article
Language:English
Published: 15 March 2012
ISSN:1432-2307
Item Description:Gesehen am 12.10.2018
Physical Description:8
DOI:10.1007/s00428-012-1219-x
Subjects:
QR Code: Show QR Code